Elevance Health Board Welcomes Amy Schulman as New Director, Reflecting Ongoing Commitment to Governance Excellence

Core Viewpoint - Elevance Health has appointed Amy Schulman as an independent director, effective January 12, 2026, to enhance its board's expertise in healthcare innovation and governance [1][2][3]. Group 1: Appointment Details - Amy Schulman will serve on the Audit and Finance Committees, bringing extensive experience in healthcare innovation and regulatory strategy [1][3]. - Schulman is currently the Managing Partner at Polaris Partners, managing over $4 billion in healthcare and technology investments [3]. Group 2: Board Strategy - The appointment is part of Elevance Health's board refreshment strategy aimed at ensuring diverse and independent leadership aligned with long-term company goals [2][4]. - The board's refreshment process is central to Elevance Health's mission of improving health outcomes while delivering sustainable, long-term value [4]. Group 3: Company Overview - Elevance Health serves 109 million consumers through a diverse portfolio of medical, pharmacy, behavioral, clinical, home health, and complex care solutions [4].